Level Four Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

Level Four Advisory Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$254K	Sell	1,335 -136	-9%	-$23.4K	0.01%	819
2026 Q1	$248K	Buy	+1,471	New	+$252K	0.01%	769
2022 Q1	–	Sell	-2,180	Closed	-$333K	–	671
2021 Q4	$333K	Buy	2,180 +21	+1%	+$3.25K	0.03%	497
2021 Q3	$349K	Sell	2,159 -520	-19%	-$87.5K	0.04%	358
2021 Q2	$438K	Sell	2,679 -64	-2%	-$9.86K	0.03%	431
2021 Q1	$413K	Sell	2,743 -233	-8%	-$37K	0.03%	422
2020 Q4	$451K	Buy	2,976 +147	+5%	+$21K	0.04%	384
2020 Q3	$383K	Sell	2,829 -536	-16%	-$72.7K	0.03%	394
2020 Q2	$457K	Buy	+3,365	New	+$429K	0.04%	380
2020 Q1	–	Sell	-2,535	Closed	-$305K	–	520
2019 Q4	$305K	Buy	2,535 +270	+12%	+$30.1K	0.01%	465
2019 Q3	$225K	Sell	2,265 -329	-13%	-$34.4K	0.02%	453
2019 Q2	$283K	Sell	2,594 -489	-16%	-$52K	0.03%	435
2019 Q1	$345K	Buy	3,083 +165	+6%	+$18.1K	0.04%	378
2018 Q4	$281K	Sell	2,918 -1,152	-28%	-$122K	0.04%	417
2018 Q3	$496K	Buy	4,070 +25	+0.6%	+$2.94K	0.05%	343
2018 Q2	$444K	Sell	4,045 -930	-19%	-$99.5K	0.03%	400
2018 Q1	$531K	Buy	4,975 +1,666	+50%	+$185K	0.04%	351
2017 Q4	$356K	Buy	3,309 +171	+5%	+$18.3K	0.03%	414
2017 Q3	$349K	Buy	3,138 +513	+20%	+$54.8K	0.03%	389
2017 Q2	$251K	Hold	2,625	–	–	0.04%	416
2017 Q1	$251K	Sell	2,625 -57	-2%	-$5.46K	0.03%	454
2016 Q4	$237K	Buy	+2,682	New	+$244K	0.03%	412

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Level Four Advisory Services's IBB Position: Q2 2026 in Review

Level Four Advisory Services reduced its iShares Biotechnology ETF (IBB) stake by 9.2% in Q2 2026, selling an estimated $23.4K and leaving 1,335 shares worth $254K. The position accounts for 0.01% of the portfolio, ranked #819.

Level Four Advisory Services first reported a position in IBB in Q4 2016 and has held it in 22 quarters since. The position peaked at $531K in Q1 2018. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Level Four Advisory Services held 1,335 shares of iShares Biotechnology ETF worth $254K as of Q2 2026.
Level Four Advisory Services sold 136 iShares Biotechnology ETF shares in Q2 2026, an estimated $23.4K.
iShares Biotechnology ETF made up 0.01% of Level Four Advisory Services's portfolio in Q2 2026, its #819 holding.
Level Four Advisory Services first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 22 quarters since.
Level Four Advisory Services's iShares Biotechnology ETF position peaked at $531K in Q1 2018.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.